Mendus Ab logo
VerifiedBiotechnology Research

Mendus Ab

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST.

7-day free trial · no credit card

Verified contacts

22

available on Kipplo

LinkedIn employees

31

11 to 50 range

Open roles

no listings

Distinct roles

18

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 22 verified contacts at Mendus Ab

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

22 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Mendus Ab

18 distinct titles indexed · top 10 shown.

  • 2immunicum ab (immu)
  • 1director process development
  • 1director r & d program management
  • 1director research
  • 1enhetsöverläkare, docent
  • 1group financial controller
  • 1manager accounting & hr
  • 1member of the board
  • 1project manager assay development and regulatory cmc
  • 1scientist
  • +8more titles

Sign up to unlock all 22 contacts at Mendus Ab

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 22 verified contacts at Mendus Ab

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Mendus Ab | Kipplo Discover